Symrise reported EUR2.08B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Avient USD 804.6M 1.6B Jun/2026
Chemours USD 1.8B 459M Jun/2026
Corteva USD 4.43B 678.08M Jun/2026
Covestro EUR 3.24B 5.46B Dec/2025
Symrise EUR 2.08B 118.33M Dec/2024
Victrex GBP 128.1M 4.2M Jun/2026